Genetic privacy, discrimination, and commercialization in the era of large-scale bio-banking

Date: June 16, 2015

Time: Noon–1:30 p.m.

Location: Nixon Peabody LLP, Gas Company Tower, 555 West Fifth Street, Los Angeles, CA 90013

As the cost of DNA sequencing has become less expensive, the ability to screen and test not simply individual genetic sequences for a particular disease, but also the entire genome of a person—known as “whole genome sequencing”—is becoming more prevalent in both biomedical research and clinical care, including new initiatives proposed and being implemented by the Obama administration, mentioned in his last State of the Union address. As a result, the public is both knowingly and unknowingly adding personal genetic information from their DNA, as well as accompanying personal information, into large-scale bio-banks, without completely understanding the implications of the practice.

Please join us for an engaging discussion on the issues of how genetic material can be used or abused. Our speaker, Debra Greenfield, an attorney and adjunct assistant professor with the UCLA Institute for Society and Genetics, will discuss issues involving genetic privacy, discrimination, and commercialization in the era of large-scale bio-banking.


  • Debra Greenfield, Attorney and Adjunct Assistant Professor, The UCLA Institute for Society and Genetics


  • Stephen Chen, Patent Agent, Nixon Peabody LLP
  • Irene Tatevosyan, Associate, Nixon Peabody LLP


Noon Registration and lunch
12:30–1:30 pm Presentation

Continuing Education

This course is eligible for 1.0 General CLE credits. See details here.

Back to top